Portal de recerca
- Inici
- Projectes i Estudis Clínics
- EVALUACION PROSPECTIVA DE LA APLICACIÓN DE UN SCORE O PUNTUACIÓN PARA LA EVALUACIÓN SEMICUANTITATIVA DE LA 123I-MIBG COMO MÉTODO DE VALORACIÓN DE LA RESPUESTA AL TRATAMIENTO Y ESTRATIFICACIÓN DE PACIENTES CON NEUROBLASTOMA DE ALTO RIESGO: MODELO EN RED DE COLABORACION MULTIDISCIPLINAR.
EVALUACION PROSPECTIVA DE LA APLICACIÓN DE UN SCORE O PUNTUACIÓN PARA LA EVALUACIÓN SEMICUANTITATIVA DE LA 123I-MIBG COMO MÉTODO DE VALORACIÓN DE LA RESPUESTA AL TRATAMIENTO Y ESTRATIFICACIÓN DE PACIENTES CON NEUROBLASTOMA DE ALTO RIESGO: MODELO EN RED DE COLABORACION MULTIDISCIPLINAR.
Dades bàsiques
- Protocol:
- GV/2015/142
- EURDRACT:
- NCT:
- Centre:
- Any inici:
- 2015
- Any de finalització:
- 2016
Objectius del projecte
CONCEDIDO
Documents
- No hi ha documents
Participants
Grups d'Investigació
Resultats de l'Assaig Clínic
(18F)FDG-PET-CT in patients with spondylodiscitis: image, clinical and laboratory findings in 10 cases
Bernal, J.; (...); Bello-Arques, P.
Meeting Abstract. 2019
[ 177 Lu]Lu-DOTA-TATE and [ 131 I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.
Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco
Article. 10.3389/fendo.2022.778322. 2022
177Lu-DOTATATE (PRRT) in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEPNETs) versus other tumors
Jimenez-Fonseca, P.; (...); Carmona-Bayonas, A.
Meeting Abstract. 2022
177-Lu-DOTATATE in 200 Patients with Neuroendocrine Tumors: Real-World Data from the SEPTRALU Registry
Carmona-Bayonas, A; (...); Jimenez-Fonseca, P
Meeting Abstract. 2020
177-Lu-DOTATATE in 382 patients with somatostatin receptor-positive advanced tumors: Real-world data from the SEPTRALU registry
Casanovas M, Mitjavila; (...); Carmona-Bayonas, A.
Meeting Abstract. 2022
177Lu-DOTATATE in advanced neuroendocrine neoplasms of different locations - Data from 552 cases in the SEPTRALU registry
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2023
177Lu-DOTATATE in advanced neuroendocrine tumours: real word data from SEPTRALU registry
Mitjavila Casanovas, M.; (...); Carmona-Bayona, A.
Meeting Abstract. 2019
18 FDG PET/CT PREDICTS DECLINE IN FUNCTIONAL RESPIRATORY TESTS IN SYSTEMIC SCLEROSIS PATIENTS BUT NOT IN RHEUMATOID ARTHRITIS PATIENTS
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6844. 2018
18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with polymyalgia rheumatica: Screening for vasculitis.
Arévalo Ruales K; (...); Román Ivorra JA
Article. 10.1016/j.reuma.2018.02.009. 2020
A rare case of diffuse and bilateral pulmonary uptake in 18 F-FDG PET/CT scan.
Olivan-Sasot, P; (...); Bello-Arques, P
Editorial Material. 10.1016/j.remn.2020.11.007. 2021
A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan.
Olivan-Sasot, P; (...); Bello-Arques, P
Article. 10.1016/j.remnie.2020.11.002. 2021
Advances in emerging drugs for the treatment of neuroblastoma
Berlanga, P, Cañete A, Castela, V
Review. 10.1080/14728214.2017.1294159. 2017
Alternatives of the pelvic sentinel lymph node migration pathway in early ovarian cancer: the simplest the best.
Lago, Victor; (...); Domingo, Santiago
Article. 10.1136/ijgc-2023-004912. 2023
Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study
Coloma, C. Salvador; (...); Santaballa, A.
Meeting Abstract. 10.1093/annonc/mdw365.69. 2016
Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68 Ga-DOTATOC PET/CT, 68 Ga-DOTATOC PET/MRI and 99m Tc-octreotide SPECT/CT. What does each scan provide?
Prado-Wohlwend, S.; (...); Bello-Arques, P.
Editorial Material. 10.1016/j.remn.2020.05.012. 2021
Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68Ga-DOTATOC PET/CT, 68Ga-DOTATOC PET/MRI and 99mTc-octreotide SPECT/CT. What does each scan provide?
Prado-Wohlwend, S; (...); Bello-Arques, P
Article. 10.1016/j.remnie.2020.08.002. 2021
Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma I-131-mIBG treatment
Chimeno, JM; (...); Montoro, A
Article. 10.1080/09553002.2019.1549755. 2018
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study.
van den Oever, Selina R; (...); Pluijm, Saskia M F
Article. 10.1007/s11764-023-01335-y. 2023
Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.
de Beijer IAE; (...); Pluijm SMF
Article. 10.1007/s11764-023-01498-8. 2023
Beyond the Briganti nomogram: Individualisation of lymphadenectomy using selective sentinel node biopsy during radical prostatectomy for prostate cancer
Monserrat-Monfort, JJ; (...); Boronat-Tormo, F
Article. 10.1016/j.acuro.2016.06.002. 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Ladenstein, R; (...); SIOP Europe Neuroblastoma Group (SIOPEN)
Article. 10.1016/S1470-2045(17)30070-0. 2017
Can We Identify Chemotherapy-Related Toxicity in Children with Cancer Through Automatized Integration of Healthcare Information Systems?
Berlanga, P; (...); Canete, A
Meeting Abstract. 2017
Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialty
Berlanga, P.; (...); Castel, V.
Article. 10.1007/s12094-015-1330-y. 2016
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
Berlanga, P; (...); Ladenstein, R
Article. 10.1016/j.ejca.2020.10.020. 2021
Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study
Lago, V; (...); Domingo, S
Article. 10.1136/ijgc-2018-000049. 2019
CLINICAL APPLICATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY OVARIAN CANCER: PHASE II CLINICAL TRIAL
Lago, V.; (...); Domingo, S.
Meeting Abstract. 10.1136/ijgc-2019-ESGO.944. 2019
Clinical experience of whole body and tumour dosimetry of 131-I-mIBG treatment for pediatric patients
Espallardo, I. Torres; (...); Prado-Wohlwend, S.
Meeting Abstract. 2023
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.
J Ribelles A; (...); Castel V
Article. 10.1038/s41598-019-50327-5. 2019
ComBat harmonization in different PET imaging scenarios
Gandia-Ferrero, M.; (...); Marti-Bonmati, L.
Meeting Abstract. 2023
Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors
Berbegall, AP; (...); Noguera, R
Article. 10.1038/onc.2015.200. 2016
Comparison between whole-body F-18-FDG PET/CT and MRI in patients with SDH gene mutation paragangliomas: a preliminary study
Olivan-Sasot, P; (...); Bello-Arques, P
Meeting Abstract. 2018
Comparison of 3D dosimetry methods in hepatic radioembolisation with Y-90 microspheres
Carrasco Vela, N.; (...); Torres-Espallardo, I.
Meeting Abstract. 2021
Comparison of protocols with respiratory-gated (4D) motion compensation in PET/CT: open-source package for quantification of phantom image quality.
Martinez-Movilla, Andrea; (...); Carles, Montserrat
Article. 10.1186/s40658-022-00509-4. 2022
Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.
de Beijer IAE; (...); Pluijm SMF
Correction. 10.1007/s11764-024-01547-w. 2024
Correlation Between Clinical Characteristics And Effective Washout Time In Patients Treated With High Radioiodine Activities
Guerrero Calatayud, C.; (...); Bello Arques, P.
Meeting Abstract. 2023
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition
Sanmartin, E; (...); Font de Mora J
Article. 10.1158/1078-0432.CCR-17-0593. 2017
Distribution of segmental chromosomal alterations in neuroblastoma.
Juan Ribelles A; (...); Castel V
Article. 10.1007/s12094-020-02497-2. 2020
Do SPECT CT and sentinel node tecnhique increase the diagnosis of metastasic disease in prostate cancer?
Perez Ardavin, J.; (...); Vera-Donoso, C. D.
Meeting Abstract. 2022
Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2023
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Mitjavila, Mercedes; (...); Carmona-Bayonas, Alberto
Article. 10.1007/s00259-023-06166-8. 2023
El nuevo reto en oncologia: la secuenciacion NGS y su aplicacion a la medicina de precision.
Calabria I; (...); Castel V
Article. 10.1016/j.anpedi.2016.05.006. 2016
Evaluation of 177Lu-DOTATATE treatment in patients with metastasic or unresectable paragangliomas and pheochromocytomas
Canon Sanchez, J.; (...); Utrera Costero, A.
Meeting Abstract. 2021
Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
Trinidad, Eva Maria; (...); de Mora, Jaime Font
Article. 10.3389/fonc.2023.1037342. 2023
FDG-PET/CT Focal Uptake on an Ocular Prosthesis
Repetto, A; (...); Bello, P
Editorial Material. 10.1097/RLU.0000000000002079. 2018
Findings in sentinel lymph node biopsy in 19 patients with ovarian cancer
Utrera, A.; (...); Vera, V.
Meeting Abstract. 2019
Free flaps as a first option for reconstruction of shoulder girdle high recurrence risk tumors.
Pérez-García A; (...); Baixauli F
Letter. 10.1002/jso.26064. 2020
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Bellini, Angela; (...); Schleiermacher, Gudrun
Article. 10.1200/JCO.21.00086. 2021
Ganglio centinela en cncer de prstata.
Martínez-Sarmiento M; (...); Boronat-Tormo F
Abstract of Published Item. 2019
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.
Gargallo P; (...); Cañete A
Article. 10.3390/cancers13215339. 2021
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition
Gargallo, Pablo; (...); Font de Mora, Jaime
Article. 10.1038/s41431-022-01105-x. 2022
Global Retinoblastoma Presentation and Analysis by National Income Level.
Global Retinoblastoma Study Group; (...); Bowman R
Article. 10.1001/jamaoncol.2019.6716. 2020
Hepatocarcinoma, our experience with radioembolization treatment
Olivan-Sasot, P; (...); Olivas-Arroyo, C
Meeting Abstract. 2018
I-131-MIBG treatment in patients with metastatic paraganglioma and pheocrhomocytoma
Bernal, J; (...); Bello, P
Meeting Abstract. 2020
Imaging and CSF biomarkers for cognitive impairment
Agudelo, M.; (...); Bello-Arques, P.
Meeting Abstract. 2019
Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma
Torres-Vega E; (...); Bataller L
Article. 10.1016/j.jneuroim.2016.05.015. 2016
Individualised dosimetry in patients with differentiated thyroid cancer based on external dose-rate. Optimisation of the number of measurements
Bautista-Ballesteros, JA; (...); Marti-Bonmati, L
Article. 10.1016/j.remn.2015.09.009. 2016
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets.
Coronado, Esther; (...); Font de Mora, Jaime
Article. 10.1002/1878-0261.12868. 2021
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.
de Beijer, Ismay A E; (...); Chronaki, Catherine
Article. 10.2196/49910. 2024
Landscape of early clinical trials for childhood and adolescence cancer in Spain
Bautista F; (...); Moreno L
Article. 10.1007/s12094-015-1421-9. 2016
Less is more: Usefulness of the sentinel node technique in radical prostatectomy
Perez Ardavin, J.; (...); Vera-Donoso, C. D.
Meeting Abstract. 2022
Li-Fraumeni syndrome heterogeneity.
Gargallo P; (...); Cañete A
Review. 10.1007/s12094-019-02236-2. 2020
Li-Fraumeni: Will the detection in families increase the survival of its members?
Gargallo, P; (...); Canete, A
Letter. 10.1016/j.anpedi.2018.03.009. 2019
Liquid Biopsies of Patients with HIGH-RISK Neuroblastoma Disclose Exosomal miRNA Modulation after the Induction Therapy
Morini, M; (...); Varesio, L
Meeting Abstract. 2017
Liquid Biopsy Micro-RNA Profiling in Meduloblastoma
Yanez, Y; (...); Canete, A
Meeting Abstract. 2018
Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA.
Trinidad EM; (...); Font de Mora J
Article. 10.1093/bib/bbac575. 2023
Low activity treatment with I-131 in differentiated thyroid cancer
Olivan-Sasot, P; (...); Bello-Arques, P
Meeting Abstract. 2018
Lu-177-DOTATATE therapy in advanced pancreatic neuroendocrine tumors: data from 187 patients of the national registry SEPTRALU
Mitjavila-Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2022
Lu-177-DOTATATE treatment in neuroendocrine tumours. A preliminary study
Hervas, I; (...); Yepes, AM
Article. 10.1016/j.remn.2016.10.003. 2017
Lu-177-DOTATATE Treatment In Unresectable Neuroendocrine Tumors: Our Experience
Agudelo, M; (...); Figueroa-Ardila, G
Meeting Abstract. 2018
Lutetium177 in patients with stage IV neuroendocrine tumours of any origin. Data from 321 patients of the multicenter national registry
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2021
Lymphoscintigraphic findings in patients with lipedema
Olivan-Sasot, P; (...); Bello-Arques, P
Meeting Abstract. 2017
Medical imaging clinical trials unit: A professional need.
Penades-Blasco, Ana; (...); Marti-Bonmati, Luis
Article. 10.1016/j.ejrad.2021.110099. 2022
Metaiodobenzylguanidine and Neuroblastoma
Balaguer, J; (...); Castel, V
Review. 10.1055/s-0036-1572362. 2015
Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
Di Cataldo, A; (...); Canete, A
Article. 10.1007/s12094-016-1505-1. 2017
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
Berlanga P; (...); Font de Mora J
Article. 10.1016/j.molonc.2016.04.004. 2016
Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.
Reinal, Ignacio; (...); Sepulveda, Pilar
Article. 10.3390/antiox12071378. 2023
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
Olivera, GG; (...); Herrero, MJ
Article. 10.3390/ijms21082714. 2020
Nefroblastoma. Experiencia a largo plazo en el abordaje multidisciplinario.
Rodriguez Iglesias P; (...); Boronat Tormo F
Abstract of Published Item. 2018
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
Ribelles, AJ; (...); Canete, A
Article. 10.3390/jpm11040268. 2021
Our experience in Sentinel lymph node biopsy after neoadjuvant chemotherapy treatment
Utrera, A; (...); Vera, V
Meeting Abstract. 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
Nobre L; (...); Tabori U
Article. 10.1200/PO.19.00298. 2020
Paediatric tumour boards in Spain: a national survey
Berlanga, P; (...); Canete, A
Article. 10.1007/s12094-015-1466-9. 2016
Pan-Costochondritis Caused by Aspergillus Diagnosed by 18F-FDG PET/CT
Olivan-Sasot, P; (...); Bello-Arques, P
Editorial Material. 10.1097/RLU.0000000000002237. 2018
Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry
Mitjavila, M; (...); Jimenez-Fonseca, P
Meeting Abstract. 2019
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Vo, Kieuhoa T.; (...); Matthay, Katherine K.
Article. 10.1002/pbc.29616. 2022
Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE (177Lu) Is Effective and Safe in Patients with Pretreated Metastatic Neuroendocrine Tumors: Data from Spanish SEPTRALU Registry
Bello, P; (...); Mitjavila, M
Meeting Abstract. 2019
Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.
del Olmo-Garcia, Maria I.; (...); Merino-Torres, Juan F.
Article. 10.3390/cancers14030584. 2022
Peptide receptor radionuclide therapy with [(177)Lu]Lu-DOTA-TATE.
Prado-Wohlwend S; (...); Endocrinology Working Group of the SEMNIM
Article. 10.1016/j.remnie.2021.11.001. 2022
Peptide receptor radionuclide therapy with [Lu-177]Lu-DOTA-TATE
Prado-Wohlwend, S.; (...); SEMNIM
Article. 2022
Pericardial synovial tumor, a rare entity to diagnose by imaging.
Utrera-Costero A; (...); Bernal-Vergara JC
Editorial Material. 10.1016/j.remn.2020.10.005. 2021
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.
Urtasun, Andrea; (...); Herrero, Maria Jose
Article. 10.3390/cancers15051424. 2023
PHARMACOGENETIC VARIANTS ASSOCIATED WITH TREATMENT RESPONSE IN NEUROBLASTOMA
Olivera, G; (...); Alino, SF
Meeting Abstract. 2018
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
Olivera, Gladys; (...); Alino, Salvador F.
Review. 10.20517/cdr.2018.25. 2019
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
Olivera, GG; (...); Herrero, MJ
Review. 10.3390/ijms22189815. 2021
Pilot performance of a dedicated prostate PET suitable for diagnosis and biopsy guidance
Canizares, G; (...); Gonzalez, AJ
Article. 10.1186/s40658-020-00305-y. 2020
Plasma Metabolomic Profiling Differentiates High- and Low-Risk Neuroblastoma Patients
Quintas, G; (...); Segura, V
Meeting Abstract. 2018
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience
Berlanga, Pablo; (...); Castel, Victoria
Article. 10.1097/MPH.0000000000000546. 2016
Precision medicine in Ewing sarcoma: a translational point of view.
Gargallo P; (...); Cañete A
Review. 10.1007/s12094-020-02298-7. 2020
Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection
Mitjavila Casanovas, M.; (...); Carmona-Bayonas, A.
Meeting Abstract. 2024
Preliminary results of activity-time curves analysis in PET/CT F-18-Choline in treated cerebral tumors
Olivan-Sasot, P; (...); Bello-Arques, P
Meeting Abstract. 2018
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience
Berlanga, Pablo; (...); Castel, Victoria
Article. 10.1097/MPH.0000000000000270. 2015
Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal
del Olmo-Garcia, MI; (...); Merino-Torres, JF
Review. 10.3390/jcm9072203. 2020
Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU
Bello, P.; (...); Carmona-Bayonas, A.
Meeting Abstract. 2023
Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE
Casanovas, M. Mitjavila; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2018
Proposal of a short acquisition protocol for 18F-DOPA imaging in brain tumors:preliminary results
Orrego, N.; (...); Bello-Arques, P.
Meeting Abstract. 2024
PRRT of 200 patients from the SEPTRALU registry: real-world data
Casanovas, MM; (...); Jimenez-Fonseca, P
Meeting Abstract. 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.
Juan Ribelles A; (...); Castel V
Correction. 10.1038/s41598-020-58428-2. 2020
QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES
Martinez-Diaz, Rafael; (...); Peris-Fajarnes, Guillermo
Article. 10.5566/ias.1219. 2015
Radio theranostics in paragangliomas and pheochromocytomas
Wohlwend, S. Prado, Arques, P. Bello
Article. 10.1016/j.remn.2024.500017. 2024
Radio theranostics in paragangliomas and pheochromocytomas.
Wohlwend SP, Arques PB
Article. 10.1016/j.remnie.2024.500017. 2024
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Oliván-Sasot P; (...); Olivas-Arroyo C
Article. 10.1016/j.rx.2020.09.012. 2020
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Olivan-Sasot, P; (...); Olivas-Arroyo, C
Article. 10.1016/j.rxeng.2021.03.001. 2023
Radiological, clinical, scintigraphic and serum markers response of advanced neuroendocrine tumors treated with 177Lu-DOTATATE
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2018
Radionuclide Therapy in the Continuum of Care of Neuroendocrine Tumors: Results of the SEPTRALU Study
Mitjavila, CM; (...); Jimenez-Fonseca, P
Meeting Abstract. 2020
Response rate in cardiac resynchronization therapy patients implanted with a left ventricular quadripolar lead and the MultiPoint(TM) Pacing feature activated. QUARTO III.
Osca, Joaquin; (...); Alzueta, Javier
Article. 10.1111/eci.13935. 2022
Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.
Prado-Wohlwend, Stefan; (...); Merino-Torres JF
Article. 10.3389/fendo.2022.957172. 2022
Retinoblastoma and mosaic 13q deletion: a case report
Gargallo P; (...); Canete, A
Article. 10.1186/s40942-021-00321-9. 2021
Retinoblastoma: towards an earlier diagnosis.
Gargallo P; (...); Cañete A
Article. 10.1016/j.oftal.2018.05.003. 2018
Retreatment PRRT with 177Lu-DOTATATE in patients with progressive neuroendocrine neoplasm: Spanish clinical experience from national registry
Mitjavila Casanovas, M.; (...); Hernando, J.
Meeting Abstract. 2024
Review: Ewing Sarcoma Predisposition.
Gargallo P; (...); Cañete A
Article. 10.1007/s12253-019-00765-3. 2019
Same-day comparative protocol PET/CT-PET/MRI [68Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.
Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco
Article. 10.1186/s40644-023-00521-6. 2023
Sentinel lymph node biopsy in patients with locally advanced breast cancer with negative axilla after chemotherapy
Olivan Sasot, P.; (...); Sopena, P.
Article. 2015
Sentinel lymph node in apparent early ovarian cancer: open technique.
Article. 10.1136/ijgc-2019-000732. 2019
Sentinel lymph node technique in apparent early ovarian cancer: Laparoscopic technique.
Editorial Material. 10.1016/j.jmig.2019.09.790. 2020
SENTINEL LYMPH NODE TECHNIQUE IN EARLY STAGE OVARIAN CANCER (SENTOV): A PHASE II CLINICAL TRIAL
Lago, V.; (...); Domingo, S.
Meeting Abstract. 10.1136/ijgc-2019-ESGO.1284. 2019
Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial
Article. 10.1136/ijgc-2020-001289. 2020
SENTOV (SENTINEL LYMPH NODE TECHNIQUE IN OVARIAN CANCER): VIDEO TECHNIQUE
Lago, V.; (...); Domingo, S.
Meeting Abstract. 10.1136/ijgc-2019-ESGO.1302. 2019
SEPTRALU registry of 177-Lu-DOTATATE in neuroendocrine tumors: Data from 321 patients in clinical practice
Casanovas, MM; (...); Carmona-Bayonas, A
Meeting Abstract. 2021
Sequential treatment of High-risk Neuroblastoma combining I-131 MIBG high-dose and Topotecan. First experience
Orrego, N.; (...); Bello-Arques, P.
Meeting Abstract. 2023
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.
Del Olmo-Garcia MI; (...); Merino-Torres JF
Article. 10.3390/biomedicines9121810. 2021
Spinal cord compression syndrome in pediatric oncology: review of a series of cases in a tertiary level center.
Sánchez HM, Guill JB, Zúñiga RV
Case Reports. 10.1016/j.anpede.2024.01.008. 2024
Spinal cord compression syndrome in pediatric oncology: Review of a series of cases in a tertiary level center
Sanchez, Helena Martinez, Guill, Julia Balaguer, Zuniga, Roberto Velasco
Letter. 10.1016/j.anpedi.2023.09.013. 2024
Standardization analysis protocol proposal for isotopic ventriculography
Borrelli, P.; (...); Bello Arques, P.
Meeting Abstract. 2015
Success of the HR-NBL/SIOPEN local control trial strategy in high risk neuroblastoma patients undergoing high dose therapy with peripheral stem cell transplantation
Ladenstein, R; (...); Botterberg, T
Meeting Abstract. 2018
Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.
Tena, I; (...); Pacak, K
Article. 10.1177/1179554918763367. 2018
Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project
Juan Ribelles A; (...); Ladenstein, R
Article. 10.1007/s12094-017-1820-1. 2018
TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
Yáñez Y; (...); Castel V
Article. 10.1007/s00432-015-2054-7. 2016
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries
Alia, Donjeta B.; (...); Nyaywa, Mutale
Article. 10.1016/S2214-109X(22)00250-9. 2022
The Role of Imaging Studies in Favor of Possible Cerebellar Multiple System Atrophy: A Case Study.
Utrera-Costero, Ana; (...); Bello-Arques, Pilar
Article. 10.1097/RLU.0000000000003767. 2021
The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?
Perez-Ardavin J; (...); Vera-Donoso CD
Article. 10.23736/S1824-4785.22.03416-1. 2022
The value of F-18-FDG PET/CT in two cases of Primary Pericardial Mesothelioma
Utrera-Costero, Ana; (...); Bello-Arques, Pilar
Article. 10.1007/s12350-021-02690-y. 2021
TIAM1 variants improve clinical outcome in neuroblastoma
Sanmartin, E; (...); Font de Mora J
Article. 10.18632/oncotarget.16787. 2017
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.
Fabian, Ido Didi; (...); Bowman, Richard
Article. 10.1136/bjophthalmol-2020-316613. 2020
Two independent epigenetic biomarkers predict survival in neuroblastoma.
Yáñez Y; (...); Castel V
Article. 10.1186/s13148-015-0054-8. 2015
Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
Article. 10.1016/j.ygyno.2021.03.001. 2021
Update on iodine-refractory differentiated thyroid carcinoma
Casas, E. Abou Jokh; (...); Casas, J. A. Vallejo
Article. 10.1016/j.remn.2023.06.005. 2023
Update on iodine-refractory differentiated thyroid carcinoma.
Jokh Casas, E A; (...); Vallejo Casas, J A
Article. 10.1016/j.remnie.2023.07.003. 2023
Use of Lu-177-dotatate in the treatment of iodine refractory thyroid carcinomas
Olivan-Sasot, P; (...); Bello-Arques, P
Article. 10.1016/j.remn.2016.08.001. 2017
Usefulness Of Post Treatment SPECT/CT In Whole Body Scan For The TNM Re-Staging In Patients With Well Differentiated Thyroid Cancer (WDTC)
Yepes Agudelo, A.; (...); Martinez Sanchis, B.
Meeting Abstract. 2019
Y-90 PET/MR imaging optimization with a Bayesian penalized likelihood reconstruction algorithm.
Calatayud-Jordan, Jose; (...); Torres-Espallardo, Irene
Article. 10.1007/s13246-024-01452-7. 2024